Exploring the role of microRNAs in cancer progression and treatment resistance

Project Abstract

Cancer remains a major global health challenge, with progression and treatment resistance posing significant obstacles to effective management. The emerging field of microRNAs (miRNAs) has garnered attention for their regulatory roles in cancer development and response to therapy. This research project aims to explore the intricate role of miRNAs in cancer progression and treatment resistance, with a focus on understanding the underlying mechanisms and potential therapeutic implications. The abstract will delve into the molecular functions of miRNAs in cancer cells, highlighting their ability to modulate key signaling pathways involved in cell proliferation, invasion, and metastasis. By synthesizing existing literature and experimental data, this study aims to provide a comprehensive overview of the specific miRNAs implicated in promoting cancer progression and treatment resistance across various cancer types. Furthermore, the research methodology section will detail the experimental approaches used to investigate the expression profiles and functional significance of selected miRNAs in cancer cells. Through in vitro and in vivo studies, this project seeks to elucidate the impact of miRNAs on cancer cell behavior, including their potential role in mediating resistance to conventional chemotherapeutic agents and targeted therapies. The findings from this study will be discussed in Chapter Four, where the implications of miRNA dysregulation in cancer progression and treatment resistance will be thoroughly examined. By integrating the research outcomes with existing knowledge, this chapter will provide insights into the clinical relevance of miRNAs as diagnostic biomarkers and therapeutic targets in cancer management. In conclusion, this research project will contribute to advancing our understanding of the complex interplay between miRNAs and cancer progression, shedding light on novel strategies for overcoming treatment resistance and improving patient outcomes. The significance of this study lies in its potential to inform the development of personalized therapeutic approaches that target specific miRNAs to enhance the efficacy of cancer treatment regimens.

Project Overview